PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY END-USER • Segmentation by end-user • Comparison by end-user • Commercial users– Market size and forecast 2017-2022 • Individual users– Market size and forecast 2017-2022 • Market opportunity by end-user PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Rising cases of prostate cancer • Growing online retail sales of home insemination kits • Rising number of sperm donors at sperm banks PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Church & Dwight • INVO Bioscience • Piramal Enterprises • Rinovum Women's Health • The Cooper Companies • Vitrolife PART 15: APPENDIX • List of abbreviations Exhibit 01: Parent market Exhibit 02: Global infertility treatment market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global – Year over year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017-2022 Exhibit 18: Customer landscape Exhibit 19: Global artificial insemination market – Market share by end-users 2017-2022 (%) Exhibit 20: Comparison by end-user Exhibit 21: Commercial users – Market size and forecast 2017-2022 ($ mn) Exhibit 22: Commercial users – Year over year growth 2018-2022 (%) Exhibit 23: Individual users – Market size and forecast 2017-2022 ($ mn) Exhibit 24: Individual users – Year over year growth 2018-2022 (%) Exhibit 25: Market opportunity by end-user Exhibit 26: Global artificial insemination market – Market share by geography 2017-2022 (%) Exhibit 27: Regional comparison Exhibit 28: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 29: Americas – Year over year growth 2018-2022 (%) Exhibit 30: Top 3 countries in Americas Exhibit 31: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 32: EMEA – Year over year growth 2018-2022 (%) Exhibit 33: Top 3 countries in EMEA Exhibit 34: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 35: APAC – Year over year growth 2018-2022 (%) Exhibit 36: Top 3 countries in APAC Exhibit 37: Market opportunity Exhibit 38: Global hubs for fertility tourism Exhibit 39: Estimated cancer cases and deaths in US 2017 Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Church & Dwight overview Exhibit 46: Church & Dwight – Business segments Exhibit 47: Church & Dwight – Organizational developments Exhibit 48: Church & Dwight – Geographic focus Exhibit 49: Church & Dwight – Segment focus Exhibit 50: Church & Dwight – Key offerings Exhibit 51: INVO Bioscience overview Exhibit 52: INVO Bioscience– Business segments Exhibit 53: INVO Bioscience– Organizational developments Exhibit 54: INVO Bioscience– Geographic focus Exhibit 55: INVO Bioscience– Segment focus Exhibit 56: INVO Bioscience– Key offerings Exhibit 57: Piramal Enterprises overview Exhibit 58: Piramal Enterprises– Business segments Exhibit 59: Piramal Enterprises– Organizational developments Exhibit 60: Piramal Enterprises– Geographic focus Exhibit 61: Piramal Enterprises– Segment focus Exhibit 62: Piramal Enterprises– Key offerings Exhibit 63: Rinovum Women's Health overview Exhibit 64: Rinovum Women's Health– Business segments Exhibit 65: Rinovum Women's Health– Organizational developments Exhibit 66: Rinovum Women's Health– Geographic focus Exhibit 67: Rinovum Women's Health– Segment focus Exhibit 68: Rinovum Women's Health– Key offerings Exhibit 69: Vendor overview Exhibit 70: The Cooper Companies– Business segments Exhibit 71: The Cooper Companies– Organizational developments Exhibit 72: The Cooper Companies– Geographic focus Exhibit 73: The Cooper Companies– Segment focus Exhibit 74: The Cooper Companies– Key offerings Exhibit 75: Vendor overview Exhibit 76: Vitrolife – Business segments Exhibit 77: Vitrolife – Organizational developments Exhibit 78: Vitrolife – Geographic focus Exhibit 79: Vitrolife – Segment focus Exhibit 80: Vitrolife – Key offerings

Church & Dwight INVO Bioscience Piramal Enterprises Rinovum Women's Health The Cooper Companies Vitrolife